The Shortest Boy in Class: When Growth Velocity Overrides Reassurance
A 7-year-old boy is brought by his mother, who is worried he is the shortest in his class. Father is 178 cm, mother 165 cm; both report growing late, and his father reached final height at 19. Today the boy is 110 cm tall and 21 kg (25th percentile). Chart review shows he tracked near the 10th percentile at age 3 and has grown 4.0 cm in the past 14 months. He is prepubertal, takes no medications, and has no chronic diarrhea, headache, vomiting, or fatigue. Examination is unremarkable: no dysmorphic features, normal thyroid, prepubertal genitalia, proportionate limbs. Two years ago a clinician documented 'constitutional delay' and advised no testing. The mother asks whether she should keep waiting or whether 'something should be checked.'
1. Does this child's growth pattern require laboratory evaluation, or is continued observation defensible? Justify your answer using the auxological data.
Read the worked answer
Observation alone is not defensible here. Three independent features point the other way.
Height relative to genetic potential. Current height is about 2.1 SD below the mean for age. Mid-parental height is (178 + 165 + 13)/2 = 178 cm, roughly +0.3 SD. The gap between his height and his genetic target is therefore more than 2 SD - the conventional threshold at which a pathologic cause must be excluded rather than assumed away.
Growth velocity. Expected prepubertal velocity is roughly 5–6 cm/yr. He grew 4.0 cm in 14 months (about 3.4 cm/yr), which is abnormally slow. Velocity is the single most useful discriminator between constitutional delay and disease: a child with constitutional delay grows slowly in absolute terms but follows a percentile line at a normal rate.
Percentile crossing. He moved from the 10th percentile to well below the 3rd. Crossing two major percentile lines is a red flag regardless of the family history.
The family history of late growth is genuinely reassuring and makes constitutional delay the most likely single diagnosis - but it is a diagnosis of exclusion. Constitutional delay is expected to show normal velocity, a bone age delayed roughly in proportion to height age, and a predicted adult height within the parental target range. Two of those three do not fit. Proceeding to screening studies costs little and is the safer judgment call.
2. Which initial studies would you order, and why each one? State explicitly which tests you would not order at this stage and why.
Read the worked answer
Reasonable initial panel (screening, not diagnostic):
- CBC with differential and ESR or CRP - occult systemic or inflammatory disease.
- Celiac serology: tissue transglutaminase IgA plus total IgA - celiac disease is among the commonest causes of acquired short stature and is frequently silent; total IgA is needed because IgA deficiency makes the tTG falsely negative.
- TSH and free T4 - acquired hypothyroidism blunts velocity before other signs appear.
- IGF-1 and IGFBP-3 - a screen for growth hormone axis integrity. Interpret against age and pubertal status; a normal value does not exclude growth hormone deficiency, and a low value does not diagnose it.
- Basic metabolic panel with creatinine, electrolytes, bicarbonate; urinalysis - renal tubular acidosis, chronic kidney disease.
- Bone age radiograph of the left hand and wrist - radiation is negligible; it separates bone age delay proportionate to height age (constitutional) from disproportionate delay (endocrine) and improves adult height prediction.
Not at this stage: growth hormone stimulation testing (requires standardized priming and is a subspecialty test, not a screen); brain MRI (only for confirmed growth hormone deficiency, neurologic signs, or headache); karyotype (reserved for girls, where Turner syndrome is the concern); and broad genetic panels before the cheap, common causes are excluded. Ordering a definitive test first invites mislabeling a normal variant as disease.
3. The family asks about growth hormone and about the bone age radiograph. How do you counsel them, and what would prompt endocrinology referral?
Read the worked answer
Bone age: explain that it is a single hand x-ray with minimal radiation, that it estimates skeletal maturity, and that its value is in interpretation - it helps predict adult height and shows whether his bones are 'younger' than his age. It does not commit him to any treatment.
Growth hormone: be direct that growth hormone is not indicated on the basis of short stature alone. It is approved for confirmed growth hormone deficiency, being small for gestational age without catch-up, Turner syndrome, Prader-Willi, and a small number of other defined conditions. In idiopathic short stature the average height gain is modest, treatment means years of daily injections, and there are real costs and potential adverse effects. Framing this now prevents the expectation that a 'growth shot' is the next step.
The plan I would state explicitly: complete the screening labs and bone age, review them at a scheduled visit, and start six-monthly stadiometry with a wall-mounted device, plotting velocity rather than height alone. Referral to pediatric endocrinology if any screening test is abnormal, if velocity stays below about 4–5 cm/yr over a further 6–12 months, if height falls further away from the mid-parental target, or if the bone age is markedly discordant. Also ask about school, teasing, and mood - the psychosocial burden is part of the problem even when the growth is benign, and a family that feels heard is more likely to accept watchful waiting.